Dr. John Cush RheumNow
3 years 4 months ago
With AI and GPT-4... "The cognitive speed limit has just been lifted." - John Nosta https://t.co/mMXos8LLt6 https://t.co/imBfp37J1l
Dr. John Cush RheumNow
3 years 4 months ago
Spanish Society of Rheumatology (SER) study finds w/ retirement of many older (male) Rheums; there are workforce shortages. Most (59.7%) of rheums in Spain are women, the majority below age 54 yrs. https://t.co/DPs0S63Aqc https://t.co/ig4kOQWmkn
Dr. John Cush RheumNow
3 years 4 months ago
vit D shows no change in Fx Risk. Study of 20,326 Australians given placebo or vit D3 60K IU/mo. 46% women, age 69 yrs. W/ 5.1 yrs F/U - no effect on Fx risk (HR 0·94; 0·84–1·06). Fx in 5.6% of Vit D vs 5.9% in PBO (non-vertebral, major OP & hip Fxs https://t.co/cSbTS3xWrX https://t.co/Jipzw28Wn8
Networking provides the framework for an exchange of ideas and new opportunities that can actually open doors.
Dr. John Cush RheumNow
3 years 4 months ago
Antiphospholipid Antibodies With Incident Cardiovascular Events
Are antiphospholipid antibodies (aPL) associated with atherosclerotic cardiovascular (ASCVD) event risk?
https://t.co/XQk17P6D2f https://t.co/y5exrsicW8
Dr. John Cush RheumNow
3 years 4 months ago
RheumThoughts: Changing the Conversation with Patients: Lupus
Join the discussion! RheumThoughts are opinion pieces from healthcare professionals.
https://t.co/NcJcCZVlbE
@drbags71 https://t.co/VfAqUkqLak
Dr. John Cush RheumNow
3 years 4 months ago
RheumNow Presents Women In Rheumatology: Contract Negotiations https://t.co/nkAu5kQj2w
Dr. John Cush RheumNow
3 years 4 months ago
TONIGHT! Tuesday Night Rheumatology addresses Contract Negotiations, featuring Andrea Liberatore, JD, Gwenesta Melton, MD, and Kathryn Dao, MD.
Sign up to attend this and all of our Tuesday Night Rheumatology series.
@uptoTate @KDAO2011
https://t.co/L2WMLnnJhV https://t.co/Z4kEBJHBjz
Dr. John Cush RheumNow
3 years 4 months ago
Probiotic strain Ligilactobacillus salivarius studied in gout (as it metabolizes purines). 30 pts w/ hyperuricemia & recurrent gout were given L. salivarius or allopurinol for 6 mos. Probiotic group had less gout attacks (5/15) than controls (13/15). https://t.co/njPZdKhBxv https://t.co/YO27M8p5Ki
A prospective, cross-sectional analysis of patients with rheumatoid arthritis (RA) shows those with interstitial lung disease (ILD) tend to be older, obese and have a smoking history.
A single-center cohort study of 148 RA-ILD and 410 RA-non ILD patients compared clinical features clinical features to identify distinguishing features associated with RA-ILD.
Dr. John Cush RheumNow
3 years 4 months ago
April's Therapeutic Update focuses on gender differences in disease states and therapeutic outcomes. Sex Differences in axSpA and PsA, Gender Differences in Vasculitis, and Gender Differences in Counseling Patients on Reproductive Health now available.
https://t.co/M9kUr44Zwj https://t.co/LFPpnLMK4D
Dr. John Cush RheumNow
3 years 4 months ago
Commercial claims analysis shows a significant association between acne and incident #IBD (OR 1.42; 1.23-1.65), but not with the drugs used to treat acne (tetracycline-class Abx or isotretinoin) https://t.co/VSHMRw4z7c https://t.co/S2o6Xw3Mfd
Dr. John Cush RheumNow
3 years 4 months ago
Anakinra Phase 2/3 study in severe hosp. COVID-19 pts (5/20-3/21) w/ pneumonia & hyperinflammation (incr levels IL-6, ferritin, CRP, LDH). 179 pt Rx w/ ANA or SOC - d15 need for Mech ventilation was 77% ANAK v 86% SoC (NS; RR 0.90; 0.77-1.04) https://t.co/CFcI1qTsU2 https://t.co/wAj4pHN5Dh
Dr. John Cush RheumNow
3 years 4 months ago
Mentoring is Personal
Dr. Una Makris shares her experience finding and becoming a mentor to rheumatologists.
https://t.co/MEW1b0lAnE https://t.co/kxdJ3bafsr
Dr. John Cush RheumNow
3 years 4 months ago
NEJM Clinical image: 61-year-old woman presented with a 6-month history of periorbital swelling and shoulder weakness. The physical examination was notable for erythema of the upper and lower eyelids and substantial periorbital edema. Dermatomyositis. https://t.co/1Vu1Lh37Hd https://t.co/Bh7FXDgMRx
